Neutrogena Beach Defense Sunscreen Spray Recalled for cGMP Deviations
Johnson & Johnson Consumer, Inc. is recalling Neutrogena Beach Defense water+sun protection sunscreen spray (SPF 60+) due to current good manufacturing practice (cGMP) deviations. The recall is voluntary and affects nationwide distribution in the US.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is FDA Class II and was initiated voluntarily by the firm due to manufacturing deviations. No illnesses or injuries are reported in the source material, and the hazard is process-related rather than involving a specific harmful substance or contamination.
Plain-English summary
Johnson & Johnson Consumer, Inc. is voluntarily recalling Neutrogena Beach Defense water+sun protection sunscreen spray BROAD SPECTRUM SPF 60+ (8.5 oz/240 g aerosol cans) distributed nationwide in the United States. The product contains Avobenzone (3%), Homosalate (10%), Octisalate (5%), and Octocrylene (10%).
The recall was initiated due to current good manufacturing practice (cGMP) deviations identified during manufacturing. The recall includes all lots within their expiration dates.
Consumers who have purchased this product should stop using it. The company initiated this recall on July 14, 2021, and the FDA classified it on September 24, 2021. Additional information may be available on the FDA's Drug Recalls webpage.
The recalled product
- Product
- Neutrogena Beach Defense water+sun protection sunscreen spray BROAD SPECTRUM SPF 60+, Avobenzone (3%), Homosalate (10%), Octisalate (5%), Octocrylene (10%) NET WT. 8.5 OZ. (240 g) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NJ 08858, UPC 0 86800 11255
- Manufacturer
- Johnson & Johnson Consumer, Inc.
- Category
- Drug — Sunscreen / Topical
- Hazard
- cgmp-deviations
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27